Drugs / UCB-MSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06078059 | Nov 2022 → Oct 2024 | osteoarthritis, knee | University Medical Centre Ljubljana | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UCB-MSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06078059 ↗ |
| Modality | Cell therapy | “received a single intra-articular injection of 20 × 106 allogeneic UC-MSCs.” PMID 42060495 ↗ Apr 2026 |
| Route | Other | “received a single intra-articular injection of 20 × 106 allogeneic UC-MSCs.” PMID 42060495 ↗ Apr 2026 |